BRAND_ANALYSIS #ROCHE HEALTH & PHARMA #20 OF 26 IN HEALTH & PHARMA ALIGNED

Roche

· Private · Updated 25 May 2026 11:16 UTC
#802 of 1208 overall by tension · #20 of 26 in Health & Pharma
12 Aligned
The Balanced
Analysis

A pharmaceutical titan trapped in the middle—balanced C/B scores (57/69) suggest Roche has neither captured cultural momentum nor decisively won on pure business metrics. The silence around stock performance hints at a company coasting on legacy rather than momentum.

IN THE NEWS (100 articles this week)
Roche, Medicines Patent Pool sign deal to expand access to influenza drug - Reuters
Reminder: Invitation to Roche’s Investor Event at ASCO 2026 - Roche
Roche to Acquire PathAI to Drive Diagnostics - Imaging Technology News
Cultural Score
57 / 100
Business Score
69 / 100
TREND
TENSION▁▁▁▁▁▁▁▂▁▁▁▁▁▁
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▅▄▅▅▅▅▅▆▅▅▅▅▅▅
TREND CHART
Loading...
CULTURAL BREAKDOWN
Wikipedia Momentum 15/40
News Presence 43/35
Search InterestRedistributed to other dimensions
BUSINESS BREAKDOWN
Stock Momentum 0/30
Market Position 0/25
Revenue Growth 0/25
Earnings Health 0/20
BRANDS LIKE THIS
Medtronic
C:55 B:68 T:13
Calm
C:53 B:64 T:11
Sanofi
C:50 B:62 T:12
BLACKPINK
C:57 B:69 T:12
Boots
C:57 B:69 T:12
SHARE
Roche's tension is 12. Commerce outpacing culture. sociologyofcapitalism.com/brand/roche
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/roche.html" width="320" height="200" frameborder="0"></iframe>
Data: Wikipedia Pageviews, Google News RSS, AI Sentiment
All scores approximate. Updated daily.
Sociology of Capitalism
Mike Litman